In the same study, 12 of 22 upregulated miRNAs showed a significant upregulation, following pre-neoadjuvant chemotherapy, and thus play key roles in several pathways related to BC drug resistance, such as p53, Wnt, MAPK, and ErbB signaling pathways (Zhong et al., 2016). This evidence concerns the gene EGFR and breast cancer.